GLP-1 drugs, also called GLP-1 agonists, are shortened names for glucagon-like peptide-1 receptor agonists
Doi: 18
Wegovy is licensed in the UK in doses up to 2.4mg for weight loss and, on 14 September 2025, Novo Nordisk published results of a phase IIIb clinical trial (STEP UP, NCT05646706) of a 7.2mg dose of semaglutide for subcutaneous injection 1
Skin Laxity After GLP-1 Weight Loss A realistic, non-surgical plan for tightening skin, restoring structure, and looking like yourself again There is a moment many patients describe after a successful GLP-1 weight loss journey, the scale finally reflects the work, the clothes fit, energy is back, and then the mirror delivers a surprise
and follow-up visits support dose titration and side-effect management
As such, centrally, but not peripherally, administered nesfatin-1 reproducibly causes reductions in food intake in rodents 231,232